Compare EXTR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXTR | STAA |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Ophthalmic Goods |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.2B |
| IPO Year | 1999 | N/A |
| Metric | EXTR | STAA |
|---|---|---|
| Price | $16.64 | $26.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 10 |
| Target Price | $21.80 | ★ $24.56 |
| AVG Volume (30 Days) | 1.2M | ★ 1.3M |
| Earning Date | 01-28-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $1,181,108,000.00 | $230,591,000.00 |
| Revenue This Year | $12.45 | N/A |
| Revenue Next Year | $7.33 | $22.61 |
| P/E Ratio | $281.29 | ★ N/A |
| Revenue Growth | ★ 14.31 | N/A |
| 52 Week Low | $10.10 | $13.50 |
| 52 Week High | $22.89 | $30.81 |
| Indicator | EXTR | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 52.87 |
| Support Level | $16.99 | $23.03 |
| Resistance Level | $18.36 | $25.35 |
| Average True Range (ATR) | 0.44 | 1.18 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 4.18 | 69.56 |
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.